What was COLGATE PALMOLIVE CO's revenue in fiscal 2025?

COLGATE PALMOLIVE CO reported revenue of $20.38B for fiscal 2025, up 1.4% from fiscal 2024.

What is COLGATE PALMOLIVE CO's net margin?

Operating margin was 16.2% and net margin was 10.5%, against a median net margin of 12.8% across S&P 500 members for the same fiscal year.

What is COLGATE PALMOLIVE CO's diluted EPS?

Diluted EPS was $2.63, down 25.1% from the prior year.

Are COLGATE PALMOLIVE CO insiders buying or selling shares?

Over the past 12 months, insiders reported 15 open-market sales totalling $57.1M on Form 4.

Which institutions hold COLGATE PALMOLIVE CO stock?

2,910 institutions reported holding COLGATE PALMOLIVE CO shares in 13F filings for the quarter ended June 30, 2026; the largest reported position was Banque Cantonale Vaudoise's.

Overview

COLGATE PALMOLIVE CO

CLNYSEConsumer StaplesPerfumes, Cosmetics & Other Toilet PreparationsCIK 0000021665Large-cap benchmark

Latest 10-K: FY2025, filed Feb 23, 2026 · Open the 10-K (Inline XBRL) ↗

Ask about CL in Workspace

Revenue: $20.38B; 1.4%YoYup from FY2024; TotalRevenue
Gross profit: $12.25B; 0.7%YoYup from FY2024; GrossProfit
Operating income: $3.31B; 22.5%YoYdown from FY2024; OperatingIncome
Net income: $2.13B; 26.2%YoYdown from FY2024; NetIncome
Diluted EPS: $2.63; 25.1%YoYdown from FY2024; EPSDiluted
Diluted shares: 811.1M; 1.5%YoYdown from FY2024; WeightedAvgSharesDiluted

At a glance

Growth

COLGATE PALMOLIVE CO reported revenue of $20.38B for fiscal 2025, up 1.4% from fiscal 2024.
Revenue grew faster than the median S&P 500 member in 1 of the last 5 fiscal years.

Profitability

Operating margin was 16.2% and net margin was 10.5%, against a median net margin of 12.8% across S&P 500 members for the same fiscal year.

Per share

Diluted EPS was $2.63, down 25.1% from the prior year.

Insiders & holders

Over the past 12 months, insiders reported 15 open-market sales totalling $57.1M on Form 4.
2,910 institutions reported holding COLGATE PALMOLIVE CO shares in 13F filings for the quarter ended June 30, 2026; the largest reported position was Banque Cantonale Vaudoise's.

Written from the filed figures on this page by fixed rules — no AI.

Data as of Oct 31, 2026 · Sources: SEC EDGAR 10-K, Form 4, 13F

Quick answers

What was COLGATE PALMOLIVE CO's revenue in fiscal 2025?: COLGATE PALMOLIVE CO reported revenue of $20.38B for fiscal 2025, up 1.4% from fiscal 2024.
What is COLGATE PALMOLIVE CO's net margin?: Operating margin was 16.2% and net margin was 10.5%, against a median net margin of 12.8% across S&P 500 members for the same fiscal year.
What is COLGATE PALMOLIVE CO's diluted EPS?: Diluted EPS was $2.63, down 25.1% from the prior year.
Are COLGATE PALMOLIVE CO insiders buying or selling shares?: Over the past 12 months, insiders reported 15 open-market sales totalling $57.1M on Form 4.
Which institutions hold COLGATE PALMOLIVE CO stock?: 2,910 institutions reported holding COLGATE PALMOLIVE CO shares in 13F filings for the quarter ended June 30, 2026; the largest reported position was Banque Cantonale Vaudoise's.

Data as of Oct 31, 2026 · Sources: SEC EDGAR 10-K

Financial statements

Annual figures from the 10-K, most recent fiscal year first.

Income Statement

5 annual periods

Chip: YoY change.

Income Statement, annual, newest fiscal year first. 4Y CAGR: compound annual growth from the oldest to the newest year shown. Muted line: large-cap benchmark median change. Line under a label: how many large-cap benchmark companies its median rests on.
Line item	FY2025	FY2024	FY2023	FY2022	FY2021	4Y CAGR
Revenue	$20.38B1.4%up Benchmark median 6.4%	$20.10B3.3%up Benchmark median 4.5%	$19.46B8.3%up Benchmark median 4.8%	$17.97B3.1%up Benchmark median 10.3%	$17.42B5.8%up Benchmark median 13.8%	4.0% Benchmark median 6.6%
Gross Profit Median of 315 / 498	$12.25B0.7%up Benchmark median 6.8%	$12.16B7.4%up Benchmark median 5.5%	$11.33B10.5%up Benchmark median 5.2%	$10.25B1.2%down Benchmark median 8.3%	$10.38B3.6%up Benchmark median 15.7%	4.2% Benchmark median 6.2%
Operating Income Median of 373 / 498	$3.31B22.5%down Benchmark median 7.3%	$4.27B7.1%up Benchmark median 7.4%	$3.98B37.7%up Benchmark median 4.9%	$2.89B13.2%down Benchmark median 7.5%	$3.33B14.2%down Benchmark median 23.5%	-0.2% Benchmark median 7.2%
Net Income	$2.13B26.2%down Benchmark median 4.8%	$2.89B25.6%up Benchmark median 5.7%	$2.30B28.9%up Benchmark median 1.9%	$1.78B17.6%down Benchmark median 1.3%	$2.17B19.6%down Benchmark median 33.9%	-0.4% Benchmark median 4.1%
EPS (Diluted)	$2.6325.1%down Benchmark median 6.2%	$3.5126.7%up Benchmark median 7.9%	$2.7730.0%up Benchmark median 1.9%	$2.1316.5%down Benchmark median 1.5%	$2.5518.8%down Benchmark median 34.8%	0.8% Benchmark median 5.6%

Balance Sheet

5 annual periods

Chip: YoY change.

Balance Sheet, annual, newest fiscal year first. 4Y CAGR: compound annual growth from the oldest to the newest year shown. Muted line: large-cap benchmark median change. Line under a label: how many large-cap benchmark companies its median rests on.
Line item	FY2025	FY2024	FY2023	FY2022	FY2021	4Y CAGR
Total Assets	$16.33B1.8%up Benchmark median 5.6%	$16.05B2.1%down Benchmark median 3.4%	$16.39B4.2%up Benchmark median 4.1%	$15.73B4.6%up Benchmark median 2.2%	$15.04B5.5%down Benchmark median 6.7%	2.1% Benchmark median 4.7%
Total Liabilities Median of 357 / 498	$15.96B3.0%up Benchmark median 6.4%	$15.50B0.4%up Benchmark median 1.9%	$15.44B3.4%up Benchmark median 2.9%	$14.93B6.1%up Benchmark median 2.0%	$14.07B5.1%down Benchmark median 5.2%	3.2% Benchmark median 4.4%
Stockholders' Equity	$365.00M32.9%down Benchmark median 6.8%	$544.00M43.2%down Benchmark median 5.4%	$957.00M18.7%up Benchmark median 7.3%	$806.00M17.0%down Benchmark median 2.5%	$971.00M11.8%down Benchmark median 9.0%	-21.7% Benchmark median 6.1%
Cash & Equivalents	$1.29B17.5%up Benchmark median 5.2%	$1.10B13.5%up Benchmark median 1.9%	$0.97B24.6%up Benchmark median 6.7%	$0.78B6.9%down Benchmark median -8.6%	$0.83B6.3%down Benchmark median -2.9%	11.5% Benchmark median 2.0%
Total Debt	$7.99B0.6%up Benchmark median 2.1%	$7.94B3.6%down Benchmark median 0.2%	$8.24B5.9%down Benchmark median 0.3%	$8.76B21.5%up Benchmark median 0.1%	$7.21B1.9%down Benchmark median -0.1%	2.6% Benchmark median 4.3%

Cash Flow Statement

5 annual periods

Chip: YoY change.

Cash Flow Statement, annual, newest fiscal year first. 4Y CAGR: compound annual growth from the oldest to the newest year shown. Muted line: large-cap benchmark median change. Line under a label: how many large-cap benchmark companies its median rests on.
Line item	FY2025	FY2024	FY2023	FY2022	FY2021	4Y CAGR
Operating Cash Flow	$4.20B2.2%up Benchmark median 6.3%	$4.11B9.7%up Benchmark median 4.8%	$3.75B46.5%up Benchmark median 9.9%	$2.56B23.1%down Benchmark median -0.7%	$3.33B10.6%down Benchmark median 10.7%	6.0% Benchmark median 7.0%
Capital Expenditures	$564.00M0.5%up Benchmark median 5.4%	$561.00M20.4%down Benchmark median 2.8%	$705.00M1.3%up Benchmark median 11.3%	$696.00M22.8%up Benchmark median 14.0%	$567.00M38.6%up Benchmark median 8.1%	-0.1% Benchmark median 9.0%
Free Cash Flow Median of 378 / 498	$3.63B2.5%up Benchmark median 7.3%	$3.55B16.6%up Benchmark median 6.1%	$3.04B63.4%up Benchmark median 8.8%	$1.86B32.6%down Benchmark median -11.3%	$2.76B16.7%down Benchmark median 10.2%	7.1% Benchmark median 4.9%

n/m: not meaningful — the base (the prior year, or the first year for the CAGR) was zero or negative, or a per-share figure’s share basis changed (stock split). “—” means the figure is not available.

Benchmark median = median of the companies in the benchmark universe on Dec 31 of each fiscal year, from their own 10-K filings; a change counts only companies whose prior year was positive. Each median uses every member that reports the line item; where fewer than 80% do (banks and insurers file no gross profit), the row names how many. Published where at least 250 companies report it. Updated 2026-10-27. This compares reported figures, not share-price returns. Methodology

Ratios & valuation

FY2025

Every ratio read two ways: Wall Street’s popular formula and the value investor’s stricter one. Same question, same unit. Pick a ratio.

Valuation · Earnings yield

What a dollar of market value earned

3.3%

Wall Street

on net earnings

FY2024 3.9%

5.7%

Value investor

on free cash flow

FY2024 4.7%

Gap +2.4 pts: Value-investor figure 2.4 points higher

How it’s calculated

Wall Street · on net earnings

Diluted EPS ÷ fiscal-year-end share price (1 ÷ P/E)

pe_ratio (ratio table)

P/E 30.0×

Value investor · on free cash flow

(Operating cash flow − capital expenditures) ÷ market capitalisation (fiscal-year-end close × weighted-average diluted shares)

free cash flow ÷ market cap

Each ratio measures one thing two ways, in the same unit: the popular formula, then a stricter one, so a lower figure is the stricter reading. Gap = value-investor figure minus Wall Street figure, from the figures shown.

Price-based ratios use the fiscal-year-end closing price. Free cash flow = operating cash flow − capital expenditures (we compute it; filings rarely report it). n/m = not meaningful (denominator ≤ 0); “—” = not reported. Each ratio’s formulas are under “How it’s calculated”.

Cash & capital allocation

Where the cash went in FY2025, from the 10-K cash flow statement.

Operating cash flow: $4.20B
Capex: $564.00M
Free cash flow: $3.63B
R&D: $366.00M
Buybacks: $1.21B
Dividends: $1.82B
Debt repaid: —
Debt issued: —
Net debt change: —

Uses of operating cash flow, FY2025

Buybacks28.8%
Dividends43.4%
Capex13.4%

Each use is shown against operating cash flow on its own; the uses overlap.

Buybacks + dividends exceeded free cash flow in FY2022, FY2021.

Free cash flow by year

FY21$2.76B
FY22$1.86B
FY23$3.04B
FY24$3.55B
FY25$3.63B

Buybacks by year

FY21$1.32B
FY22$1.31B
FY23$1.13B
FY24$1.74B
FY25$1.21B

Smart money

Who is trading and holding COLGATE PALMOLIVE CO, from Form 4, 13F and 13D/13G filings.

Insiders

Insider activity · past 12 months

Open-market trades reported on Form 4 in the past 365 days.

Buys: 0; none reported
Sales: 15; 8 insiders
Value sold: $57.1M
Shares sold: 613,346
Net shares: -613,346; bought minus sold
Last trade: Aug 24, 2026

Purchases 0% of valueSales 100% of value

Latest open-market insider trades from Form 4
Insider	Type	Date	Shares	Price	Value	Filing
Tsourapas PanagiotisCOO, CD, EMEA, APac, Skin	Sell	Aug 24, 2026	10,000	$92.05	$920,500	View filing on SEC EDGAR
CAHILL JOHN TDirector	Sell	Aug 6, 2026	4,170	$93.37	$389,353	View filing on SEC EDGAR
Wallace Noel R.Chairman, President & CEO	Sell	Aug 5, 2026	161,021	$92.52	$14,897,663	View filing on SEC EDGAR

See plans

Open-market purchases (code P) and sales (code S) only. Grants, option exercises and tax withholding are excluded. Sales may be made under pre-arranged Rule 10b5-1 plans.

Ownership

Largest institutional holders

13F

Quarter ended Jun 30, 2026; change versus Mar 31, 2026.

Institutions reporting: 2,910
Top 3 hold: 12.2%; of 811.10M diluted shares, FY2025 10-K

Top 3 holders, share of diluted sharesof 100%

Banque Cantonale Vaudoise0.0%
58,349 sh · $5.3BNo prior-quarter match13F-HR · Jun 30, 2026 on SEC EDGAR
Vanguard Capital Management6.4%
52,246,333 sh · $4.8BAdded 0.1%13F-HR · Jun 30, 2026 on SEC EDGAR
STATE STREET CORP5.8%
47,020,966 sh · $4.3BTrimmed 1.5%13F-HR · Jun 30, 2026 on SEC EDGAR

See plans

Some filers' amendments could not be read, so a few holders may be counted twice.

Bars: share of diluted shares on a shared scale; the tick marks 5%. 13F filings are due 45 days after quarter end, so this is the latest fully reported quarter. Amended filings are counted once.

Blockholders, 5% and over

13D/G

SC 13D / 13G, latest filing per filer.

Filers at 5%+: 3
Combined: 21.3%; sum of latest filings
Activist (13D): 0

5%+ filers, share of the class as filedof 100%

BlackRock, Inc.8%
Passive · 13GLast filed 1 yr agoSC 13G/A · Nov 12, 2024 on SEC EDGAR
Vanguard Capital Management7.52%
Passive · 13GSC 13G · Apr 29, 2026 on SEC EDGAR
: STATE STREET CORPORATION5.79%
Passive · 13GLast filed 2 yrs agoSC 13G/A · Jan 25, 2024 on SEC EDGAR

No filer switched from a passive 13G to an activist 13D in the last 365 days.

Percent of the class as each filer last reported it; filings older than a year may no longer reflect the stake. Latest filing per filer within three years; a later filing reporting 0% removes the filer.

Full history, every insider and 13F filer, 13D/G activist stakes, and webhooks are on Institutional.

See Institutional

Smart money

Showing the most recent 5 annual periods. Get longer history on the Pro plan, or the full history (1993–present) plus the smart-money dataset and webhooks on Institutional.

Restatement Radar

6 numbers COLGATE PALMOLIVE CO later changed — same XBRL tag, both filings linked.

numbers changed: 6
restating filings: 6
came with an amendment or a non-reliance notice: 0

Feb 19, 2015 · 10-K
changed 1 number
No amendment filed
Open filing
- Total liabilitiesAs of Dec 31, 2013$11.3B restated to $11.4B+1.0%
  As reported · Feb 20, 2014us-gaap:Liabilities
Apr 27, 2018 · 10-Q
changed 1 number
No amendment filed
Open filing
- Operating incomeQ1 2017$885M restated to $912M+3.1%
  As reported · Apr 28, 2017us-gaap:OperatingIncomeLoss
Jul 27, 2018 · 10-Q
changed 1 number
No amendment filed
Open filing
- Operating incomeQ2 2017$853M restated to $878M+2.9%
  As reported · Jul 21, 2017us-gaap:OperatingIncomeLoss
Oct 26, 2018 · 10-Q
changed 1 number
No amendment filed
Open filing
- Operating incomeQ3 2017$927M restated to $957M+3.2%
  As reported · Oct 27, 2017us-gaap:OperatingIncomeLoss
Feb 21, 2019 · 10-K
changed 1 number
No amendment filed
Open filing
- Operating incomeFY 2016$3.8B restated to $4B+3.1%
  As reported · Feb 23, 2017us-gaap:OperatingIncomeLoss
Feb 21, 2020 · 10-K
changed 1 number
No amendment filed
Open filing
- Operating incomeFY 2017$3.6B restated to $3.7B+3.3%
  As reported · Feb 15, 2018us-gaap:OperatingIncomeLoss

CL is not the only one.

See every restatement we've found across the market — or get an alert the next time CL revises a number.

Restatement Radar Alert me

Restatements are detected by comparing every vintage of a fact across all of COLGATE PALMOLIVE CO's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows CL's most significant revisions, and a figure absent from it has not been certified as unrevised.

Peers, filings & research

Sector Peers

WMT· Consumer Staples

Walmart Inc.

COST· Consumer Staples

COSTCO WHOLESALE CORP /NEW

Philip Morris International Inc.

PEP· Consumer Staples

PEPSICO INC

MO· Consumer Staples

ALTRIA GROUP, INC.

MNST· Consumer Staples

Monster Beverage Corp

MDLZ· Consumer Staples

Mondelez International, Inc.

Recent SEC filings

The six newest, periodic reports and 8-Ks together. Dates are SEC filing dates.

All filings on EDGAR

Six most recent SEC filings, newest first
Form	Filing	Filed	Document
8-K	Current report (material events) · Event dated Oct 30, 2026 0000021665-26-000047 · accepted 11:56 UTC	Oct 30, 2026	Open	Filed Oct 30, 2026 · 0000021665-26-000047
10-Q	Quarterly report · Quarter ended Sep 30, 2026 0000021665-26-000048 · accepted 12:31 UTC	Oct 30, 2026	Open	Filed Oct 30, 2026 · 0000021665-26-000048
8-K	Current report (material events) · Event dated Jul 31, 2026 0000021665-26-000041 · accepted 11:58 UTC	Jul 31, 2026	Open	Filed Jul 31, 2026 · 0000021665-26-000041
10-K	Annual report · Fiscal year ended Dec 31, 2025 0000021665-26-000006 · accepted 21:03 UTC	Feb 23, 2026	Open	Filed Feb 23, 2026 · 0000021665-26-000006
10-K/A	Annual report amendment · Fiscal year ended Dec 31, 2017 0000021665-18-000006 · accepted 21:49 UTC	Feb 21, 2018	Open	Filed Feb 21, 2018 · 0000021665-18-000006
10-Q/A	Quarterly report amendment · Quarter ended Sep 30, 1994 0000950112-95-000294 · accepted 05:00 UTC	Feb 8, 1995	Open	Filed Feb 8, 1995 · 0000950112-95-000294

“Open” goes to the Inline XBRL viewer when the filing has one, else the primary document. The accession opens the EDGAR index.

Research Reports

No published research on CL yet.

Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on CL and publish the result to your public profile.

Browse the research catalog Generate one with your agent

The data behind this page

27 tables, history 1993–present. Every figure above is a row you can query.

Fundamentals

Standardized financial facts, ratios and filings.

fact: 121.4Mrows
ratio: 15.8Mrows
filing: 3.71Mrows
entity: 33,316rows

350+ standard concepts.

Built from these SEC forms

10-K
10-K/A
10-K405
10-K405/A
10-KT
10-KT/A
10-Q
10-Q/A
10-QT
10-QT/A
20-F
20-F/A
40-F
40-F/A
8-K
8-K/A
6-K
6-K/A
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-11
S-11/A
F-1
F-1/A
F-3
F-3/A
F-4
F-4/A
POS AM
10-KSB
10-KSB/A
10-QSB
10-QSB/A
DEF 14Asoon
DEF 14Csoon
DEFA14Asoon
PRE 14Asoon
DEFM14Asoon
425soon
SC TO-Tsoon
SC TO-Isoon
SC 14D9soon
SC 13E3soon
CORRESPsoon
NT 10-Ksoon
NT 10-Qsoon
NT 20-Fsoon
N-PORT-Psoon

Smart money

Insider and institutional filings.

institutional_holding: 88.6Mrows
insider_transaction: 12.1Mrows
insider_filing: 5.55Mrows
insider_ownership: 1.98Mrows

109M+ smart-money rows in all.

Built from these SEC forms

Form 3
Form 3/A
Form 4
Form 4/A
Form 5
Form 5/A
13F-HR
13F-HR/A
13F-NT
13F-NT/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
Form 144
Form 144/A

One real fact row for COLGATE PALMOLIVE CO

Fact receiptOperatingCashFlow

Operating cash flow · FY2025

$4.20B

4,198,000,000 USD

COLGATE PALMOLIVE CO reported Operating cash flow of $4.2B for fiscal year 2025 in its 10-K filed Feb 23, 2026.

Fiscal period: 2025 FY
Period end: 2025-12-31
Form: 10-K
Filed: Feb 23, 2026
Entity (CIK): 0000021665

Provenance trail

Filed with the SEC
Form 10-K, filed Feb 23, 2026.
Accession 0000021665-26-000006
Open in the Inline XBRL viewer for 0000021665-26-000006
Reported in the filing
Operating cash flow for fiscal year 2025, the period ended 2025-12-31, in USD. Valuein maps the filed line to the standard concept OperatingCashFlow.
Stored as one fact row
Every channel returns this row with the same id.
fact_id f2c43b686334f50536f6d4cb5da2f7ea0e8713c032ae4aff13b9b201187c53e4
Shown on this page
The same $4.20B appears in the Cash Flow Statement and in Cash & capital allocation.

fact rowjson

{  "entity_id": "0000021665",  "standard_concept": "OperatingCashFlow",  "fiscal_year": 2025,  "fiscal_period": "FY",  "period_end": "2025-12-31",  "numeric_value": 4198000000,  "unit": "USD",  "accession": "0000021665-26-000006",  "fact_id": "f2c43b686334f50536f6d4cb5da2f7ea0e8713c032ae4aff13b9b201187c53e4"}

Get the same data

Get your free API key

bash

# Fact-level Parquet over HTTPS, every row traced to its filingcurl -H "Authorization: Bearer $VALUEIN_API_KEY" \  https://data.valuein.biz/v1/pro/fact/0000021665.parquet \  -o cl.parquet

Read the API docs

Terminalbash

# The same tables in your notebooks and backtests; the free sample needs no token$ pip install valuein-sdk

Python

from valuein_sdk import ValueinClient with ValueinClient() as client:    sql = """        SELECT fiscal_year, numeric_value FROM fact        WHERE entity_id = '0000021665'          AND standard_concept = 'TotalRevenue'          AND fiscal_period = 'FY'    """    print(client.run_query(sql))

Install the SDK

bash

# Connect Claude or ChatGPT to the same facts, each with a fact_idhttps://mcp.valuein.biz/mcp Ask your agent:get_company_fundamentals CL   # CIK 0000021665

Connect the MCP server

bash

# Ask in plain English; every figure comes back cited to its filingTell me about CL: a quick, cited overview I can dig into.

Open CL in Workspace

One token unlocks every channel. SDK docs · MCP docs

Cite this page

Data as of Oct 31, 2026. Canonical address: https://valuein.biz/data/CL

APA-style text

Valuein. (2026, October 31). COLGATE PALMOLIVE CO (CL) financial statements, earnings power and smart-money summary [Data set]. Source: SEC EDGAR filings. https://valuein.biz/data/CL

BibTeX

@misc{valuein_cl_2026,
  author = {{Valuein}},
  title = {COLGATE PALMOLIVE CO (CL) financial statements, earnings power and smart-money summary},
  year = {2026},
  howpublished = {\url{https://valuein.biz/data/CL}},
  note = {Data as of 2026-10-31; source: SEC EDGAR filings}
}

Open 10-K in SEC Inline XBRL viewer

10-K filed Feb 23, 2026 · accession 0000021665-26-000006

Agents: every figure Valuein's tools return carries a fact_id that traces to its SEC filing.

point-in-time · survivorship-free · every number traceable to its SEC filing

View CL filings on SEC EDGAR

Index names are trademarks of their owners; Valuein is not affiliated with or endorsed by any index provider.

At a glance

Growth

Profitability

Per share

Insiders & holders

02Financial statements

Income Statement

Balance Sheet

Cash Flow Statement

Ratios & valuation

03Cash & capital allocation

Uses of operating cash flow, FY2025

Free cash flow by year

Buybacks by year

04Smart money

Insiders

Insider activity · past 12 months

Ownership

Largest institutional holders

Blockholders, 5% and over

Smart money

Feb 19, 2015 · 10-K

Apr 27, 2018 · 10-Q

Jul 27, 2018 · 10-Q

Oct 26, 2018 · 10-Q

Feb 21, 2019 · 10-K

Feb 21, 2020 · 10-K

06Peers, filings & research

Sector Peers

Recent SEC filings

Research Reports

07The data behind this page

Fundamentals

Built from these SEC forms

Smart money

Built from these SEC forms

One real fact row for COLGATE PALMOLIVE CO

Provenance trail

Get the same data

08Cite this page

Insiders & holders

03Cash & capital allocation

Uses of operating cash flow, FY2025

Free cash flow by year

Buybacks by year

04Smart money

Insiders

Insider activity · past 12 months

Ownership

Largest institutional holders

Blockholders, 5% and over

Feb 19, 2015 · 10-K

Apr 27, 2018 · 10-Q

Jul 27, 2018 · 10-Q

Oct 26, 2018 · 10-Q

Feb 21, 2019 · 10-K

Feb 21, 2020 · 10-K

Sector Peers

Recent SEC filings

07The data behind this page

Fundamentals

Built from these SEC forms

Smart money

Built from these SEC forms

One real fact row for COLGATE PALMOLIVE CO

Provenance trail

Get the same data

Financial statements

Cash & capital allocation

Smart money

Peers, filings & research

The data behind this page

Cite this page

Cash & capital allocation

Smart money

The data behind this page